Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

MARIBO DYREHOSPITAL ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   2.1% 1.7% 1.9% 2.5% 5.7% 5.4% 11.7% 11.4%   Credit score (0-100)   69 73 69 62 39 42 21 21   Credit rating   A A A BBB BBB BBB BB BB   Credit limit (kDKK)   0.2 5.9 1.4 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   4,713 5,701 5,896 6,640 6,154 6,111 0.0 0.0   EBITDA   1,000 1,468 1,020 1,300 261 487 0.0 0.0   EBIT   569 1,200 748 1,065 -126 39.9 0.0 0.0   Pre-tax profit (PTP)   500.4 1,155.6 696.8 1,007.6 -231.7 -47.7 0.0 0.0   Net earnings   389.6 899.7 543.1 787.5 -178.3 -35.2 0.0 0.0   Pre-tax profit without non-rec. items   500 1,156 697 1,008 -232 -47.7 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   5,021 4,945 4,674 8,259 10,033 9,635 0.0 0.0   Shareholders equity total   2,364 3,156 3,589 4,263 4,085 4,050 3,925 3,925   Interest-bearing liabilities   1,837 1,658 1,515 1,300 1,134 967 0.0 0.0   Balance sheet total (assets)   6,287 7,702 7,496 13,150 12,396 11,651 3,925 3,925   Net Debt   1,189 -360 -577 -2,723 -252 -212 -3,925 -3,925     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   4,713 5,701 5,896 6,640 6,154 6,111 0.0 0.0   Gross profit growth   4.3% 21.0% 3.4% 12.6% -7.3% -0.7% -100.0% 0.0%   Employees   10 10 11 12 14 13 0 0   Employee growth %   0.0% 0.0% 10.0% 9.1% 16.7% -7.1% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   6,287 7,702 7,496 13,150 12,396 11,651 3,925 3,925   Balance sheet change%   -9.1% 22.5% -2.7% 75.4% -5.7% -6.0% -66.3% 0.0%   Added value   999.7 1,467.6 1,019.5 1,300.2 109.6 487.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -741 -344 -542 3,349 1,387 -845 -9,635 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   4.0 5.0 5.0 5.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   12.1% 21.0% 12.7% 16.0% -2.0% 0.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   8.8% 17.3% 9.9% 10.4% -1.0% 0.5% 0.0% 0.0%   ROI %   10.3% 21.2% 12.0% 16.3% -1.9% 0.9% 0.0% 0.0%   ROE %   17.5% 32.6% 16.1% 20.1% -4.3% -0.9% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   37.6% 41.0% 47.9% 32.4% 33.0% 34.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   118.9% -24.5% -56.6% -209.4% -96.5% -43.5% 0.0% 0.0%   Gearing %   77.7% 52.5% 42.2% 30.5% 27.8% 23.9% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.4% 3.3% 3.4% 4.3% 9.0% 9.8% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.5 1.1 1.3 0.6 0.3 0.3 0.0 0.0   Current Ratio   0.7 1.2 1.5 0.7 0.4 0.4 0.0 0.0   Cash and cash equivalent   648.5 2,017.7 2,092.4 4,023.4 1,385.3 1,179.0 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -580.5 527.1 1,000.8 -1,973.0 -4,042.4 -3,736.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   100 147 93 108 8 37 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   100 147 93 108 19 37 0 0   EBIT / employee   57 120 68 89 -9 3 0 0   Net earnings / employee   39 90 49 66 -13 -3 0 0